Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Assets Average (2019 - 2025)

Inventiva (IVEVF) posted Assets Average of $246.5 million for Q4 2025, up 49.53% on a QoQ basis from $164.8 million in Q2 2025, and up 233.48% year-over-year from $73.9 million in Q4 2024.

Analysis

Inventiva (IVEVF) Assets Average (2019 - 2025) Analysis & Trends

Inventiva has reported Assets Average for 7 years, with the latest figure at $246.5 million in Q4 2025.

  • On a quarterly basis, Assets Average rose 233.48% year-over-year to $246.5 million in Q4 2025; TTM through Dec 2025 was $246.5 million, a 233.48% increase from a year earlier, with the FY2025 full-year figure at $208.8 million, up 106.75% from the prior year.
  • Assets Average was $246.5 million for Q4 2025 at Inventiva, up from $164.8 million in the prior quarter.
  • The five-year high for Assets Average was $246.5 million in Q4 2025, with the low at $47.8 million in Q2 2024.
  • Average Assets Average over 5 years is $128.8 million, with a median of $134.0 million recorded in 2021.
  • The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 51.11% in 2024, then soared 245.03% in 2025.
  • Over 5 years, Assets Average stood at $140.4 million in 2021, then dropped by 9.08% to $127.6 million in 2022, then tumbled by 40.46% to $76.0 million in 2023, then fell by 2.71% to $73.9 million in 2024, then surged by 233.48% to $246.5 million in 2025.
  • The last three Assets Average figures came in at $246.5 million (Q4 2025), $164.8 million (Q2 2025), and $73.9 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 200.98 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 135.79 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 120.28 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - 3.29 Bn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 6.97 Bn
10 Inventiva 693.72 Mn 693.72 Mn - 246.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 246.51 Mn
Jun 30, 2025 164.85 Mn
Dec 31, 2024 73.92 Mn
Jun 30, 2024 47.78 Mn
Dec 31, 2023 75.98 Mn
Jun 30, 2023 97.73 Mn
Jun 30, 2022 127.60 Mn
Dec 31, 2021 140.35 Mn
Jun 30, 2021 150.32 Mn
Mar 31, 2021 162.56 Mn
Dec 31, 2020 120.66 Mn
Dec 31, 2019 77.07 Mn